• LAST PRICE
    0.5901
  • TODAY'S CHANGE (%)
    Trending Up0.0118 (2.0405%)
  • Bid / Lots
    0.5900/ 2
  • Ask / Lots
    0.6000/ 1
  • Open / Previous Close
    0.6090 / 0.5783
  • Day Range
    Low 0.5801
    High 0.6332
  • 52 Week Range
    Low 0.3750
    High 3.4000
  • Volume
    160,071
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.5783
TimeVolumeNLTX
09:32 ET1610.609
09:39 ET1790.61
09:42 ET1000.61
09:44 ET11080.600001
09:51 ET12840.599999
10:08 ET2250.5801
10:27 ET1000.5803
10:31 ET30000.580201
10:38 ET116000.5802
10:54 ET2000.6001
10:56 ET2000.5868
11:00 ET1000.619899
11:03 ET7500.6185
11:12 ET1700.599349
11:27 ET10000.5991
11:30 ET33000.5802
11:48 ET241960.5806
11:50 ET353120.581
11:54 ET9000.5995
11:56 ET1000.5995
11:57 ET9000.5995
11:59 ET4000.604
12:01 ET106000.604
12:03 ET7000.6
12:06 ET2000.604
12:08 ET30190.6
12:10 ET2000.6
12:15 ET54550.618
12:17 ET76000.6176
12:19 ET1000.604
12:21 ET76000.5997
12:26 ET2000.608
12:28 ET1000.6047
12:33 ET10000.6042
12:35 ET10690.6177
12:44 ET15000.617899
12:53 ET3000.6078
01:02 ET5000.6044
01:06 ET1000.6078
01:09 ET1000.6078
01:24 ET7000.6078
01:26 ET1000.61
01:27 ET3480.6006
02:20 ET10000.6068
02:30 ET3000.5999
03:33 ET114400.6299
03:35 ET26000.6318
03:37 ET83910.6243
03:46 ET3500.615
03:48 ET1000.6196
03:57 ET43310.5901
04:00 ET5000.5901
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNLTX
Neoleukin Therapeutics Inc
25.1M
-0.5x
---
United StatesRUBY
Rubius Therapeutics Inc
25.2M
-0.1x
---
United StatesELEV
Elevation Oncology Inc
24.7M
-0.3x
---
United StatesCMMB
Chemomab Therapeutics Ltd
25.6M
-0.1x
---
United StatesCHEK
Check Cap Ltd
24.7M
-4.4x
---
United StatesAMTI
Applied Molecular Transport Inc.
24.1M
-0.2x
---
As of 2023-02-04

Company Information

Neoleukin Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. The Company's lead product candidate, NL-201, is an interleukin-2 (IL-2)/ interleukin-15 (IL-15) immunotherapy designed to eliminate binding to the alpha subunit of the IL-2 receptor (also known as CD25) while enhancing binding to the beta and gamma subunits. NL-201 is designed to mimic the therapeutic activity of the cytokines IL-2 and IL-15 for the treatment of various types of cancer, including renal cell carcinoma (RCC), melanoma and hematological malignancies. Its Neoleukin platform uses a set of advanced computational algorithms and methods to design functional de novo proteins. NL-201 holds promise in combination with cell therapy to expand and maintain populations of transplanted CAR-T and natural killer (NK) cells.

Contact Information

Headquarters
1616 Eastlake Ave E Ste 360SEATTLE, WA, United States 98102-3795
Phone
206-732-2133
Fax
302-655-5049

Executives

Independent Chairman of the Board
Todd Simpson
President, Chief Executive Officer, Principal Financial Officer, Director
Jonathan Drachman
Senior Vice President Legal, General Counsel
Donna Cochener
Senior Vice President - Corporate Development
Carl Walkey
Vice President, Head of Research
Bill Arthur

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$25.1M
Revenue (TTM)
$0.00
Shares Outstanding
42.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.17
EPS
$-1.07
Book Value
$3.36
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.